American Stock Exchange to Trade Options on Bioenvision, Inc.

NEW YORK, Jan. 20  /PRNewswire/ -- The American Stock Exchange(R) (Amex) (R) will launch trading in options on Monday, January 23, 2006 on the following Nasdaq Stock Market listed stocks of:

* Bioenvision, Inc. (Option Symbol: BQN/Stock Symbol: BIVN)

Bioenvision, Inc. options will open with position limits of 7,500,000 shares. The options will trade on the March expiration cycle. The specialist will be Kellogg Capital Group, LLC. Bioenvision, Inc. is a biopharmaceutical company primarily focused on the research and development of products and technologies for the treatment of cancer. The company also performs research on anti-immune diseases.

For more information on any Amex-listed company, please visit http://www.amex.com/.

The American Stock Exchange(R) (Amex(R)) is the only primary exchange that offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM).  In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 150 ETFs.  The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks.  For more information, please visit http://www.amex.com/. 

DATASOURCE: American Stock Exchange



CONTACT:  Kelsey Hubbard, American Stock Exchange, [phone],

 



Web site:  http://www.amex.com/ 

Copyright